- This event has passed.
SCIENCE SERIES: Opioid Pharmacotherapies for Primary Care and Criminal Justice Populations
May 23, 2019 @ 12:00 pm - 1:00 pm
Title: Opioid Pharmacotherapies for Primary Care and Criminal Justice Populations: Low Threshold, Low Barrier Approaches to Naltrexone and Buprenorphine Treatments
When: Thursday, May 23, 2019, 12:00-1:00 PM Eastern Standard Time
Where: 46 Centerra Parkway, Aquarium Conference Room, Suite 315, Lebanon, NH 03766 or via WebEx
Topic description: Clinical trials and practice-based research indicates a relatively simple, medical management approaches to opioid use disorder treatments are feasible, effective, and easily disseminated. These ‘low threshold’ models value wide inclusion criteria, minimal additional mandates for counseling or psychosocial supports, immediate and sustained access to medications, and regular but not intensive follow-up to support medication adherence and good clinical outcomes. We have conducted multiple clinical trials using these low threshold, low barrier packaging of buprenorphine and naltrexone therapies for opioid use disorder in primary care settings, among detox-to-outpatient cohorts, and in jail-to-community and parole/probation populations.
About the presenter: Joshua D. Lee, MD, MSc, is an Associate Professor of Population Health and Medicine/General Internal Medicine and Clinical Innovation at the NYU School of Medicine and Director of the NYU Fellowship in Addiction Medicine. He is a clinician researcher focused on addiction pharmacotherapies in primary care as and criminal justice populations. He has conducted multiple NIH clinical trials examining the use of naltrexone and buprenorphine opioid and alcohol treatments in community criminal justice involved adults, at release from jail, and within community primary care settings.
Credit: Attendees can claim 1.0 CME/CEU for this session
Email Northeast.Node.CTN@dartmouth.edu for more details